Park Ha Biological Technology (BYAH) Accumulated Expenses (2023 - 2026)

Park Ha Biological Technology has reported Accumulated Expenses for 4 years, with the latest figure at $165964.0 in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 10.85% year-over-year to $165964.0 in Q2 2026; TTM through Apr 2026 was $165964.0, a 10.85% increase from a year earlier, with the FY2025 full-year figure at $188312.0, up 20.82% from the prior year.
• Accumulated Expenses was $165964.0 for Q2 2026 at Park Ha Biological Technology, down from $188312.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $188312.0 in Q4 2025, with the low at $125156.0 in Q4 2023.
• Average Accumulated Expenses over 4 years is $157003.2, with a median of $155863.0 recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Accumulated Expenses increased 24.53% in 2024, then grew 10.85% in 2026.
• Over 4 years, Accumulated Expenses stood at $125156.0 in 2023, then gained by 24.53% to $155863.0 in 2024, then climbed by 20.82% to $188312.0 in 2025, then retreated by 11.87% to $165964.0 in 2026.
• The last three Accumulated Expenses figures came in at $165964.0 (Q2 2026), $188312.0 (Q4 2025), and $149721.0 (Q2 2025), per Business Quant data.